Application of Traditional Vaccine Development Strategies to SARS-CoV-2
mSystems · 2023
DOI: 10.1128/msystems.00927-22 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift mSystems, 2023. Verfasst von Halie M Rando und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: COVID-19, Viral Vaccines. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 313 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
The development, production, and distribution of vaccines is imperative to saving lives, preventing illness, and reducing the economic and social burdens caused by the COVID-19 pandemic. Vaccines that use cutting-edge biotechnology have played an important role in mitigating the effects of SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Center for Health AI, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, USA.
ORCID-Profile: Halie M Rando, Ronan Lordan, Alexandra J Lee, Nils Wellhausen, Anthony Gitter, Casey S Greene
Förderung
- NHGRI NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
- NIH Medical Scientist Training Program T32
- John W. and Jeanne M. Rowe Center for Research in Virology
- Gordon and Betty Moore Foundation
- HHS | NIH | National Human Genome Research Institute
Zitieren
APA
Rando, H. M., Lordan, R., Lee, A. J., Naik, A., Wellhausen, N., Sell, E., Kolla, L., COVID-19 Review Consortium, Gitter, A., & Greene, C. S. (2023). Application of Traditional Vaccine Development Strategies to SARS-CoV-2. mSystems. https://doi.org/10.1128/msystems.00927-22
Vancouver
Rando HM, Lordan R, Lee AJ, Naik A, Wellhausen N, Sell E, et al. Application of Traditional Vaccine Development Strategies to SARS-CoV-2. mSystems. 2023. doi:10.1128/msystems.00927-22
BibTeX
@article{Rando2023,
author = {Rando, Halie M and Lordan, Ronan and Lee, Alexandra J and Naik, Amruta and Wellhausen, Nils and Sell, Elizabeth and Kolla, Likhitha and COVID-19 Review Consortium, COVID-19 Review Consortium and Gitter, Anthony and Greene, Casey S},
title = {Application of Traditional Vaccine Development Strategies to SARS-CoV-2},
journal = {mSystems},
year = {2023},
doi = {10.1128/msystems.00927-22}
}
EUVIMED